Sign Up | Log In | What is SocialPicks?

Please sign up for SocialPicks site access - it's free!

PDL BioPharma Inc (PDLI) Trade Now » Rate PDLI - Discuss PDLI - Add to Watch List

Sector: Healthcare > Industry: Biotechnology & Drugs

SocialPicks Sentiment:

** v.s. other stocks

This Quarter's Sentiment:

All:

78.5%

Top:

50.0%

Rate PDLI:

Home

Analysis & Videos

Quotes

Bull or Bear

Discuss

PDLI Analysis & Videos »

... View All >

PDLI: Bull or Bear?

PDL BioPharma: Take the LEAPS PDLI

-23.63%
in 539 days

As I pen this newsletter, I'm already seeing the Dow Industrials Index dropping by 160 points, despite the fact that oil is actually down over $1.00 per barrel today.

<>Markets seem to be detaching from the recent predictable cause-and-effect of higher oil prices = lower stock prices and vice versa. The focus is shifting...but the big question is: To what is that focus going to be on next? PIMCO's Bill Gross had an interesting June Newsletter opining on the "real" rate of global inflation vs. what the US Domestic CPI and PPI measures are showing. His very interesting observation was the ...

Continue reading »

By Daniel Jones (-33.41% risk: moderate) 06/03/08

Comment

PDLI a buy PDLI

6 %

-59.79%
in 1020 days

<>PDL BioPharma, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of therapies for life-threatening illness. The company markets three biopharmaceutical products: Cardene IV to reduce high blood pressure during or after surgery; Retavase for the improvement of ventricular function following acute myocardial infarction (AMI), the reduction of the incidence of congestive heart failure, and the reduction of mortality associated with AMI; and IV Busulfex, a chemotherapeutic agent that provides anti-tumor effect to eradicate residual malignancy, ablat...

Continue reading »

By gglquick (-48.65% risk: aggressive) 02/08/07

Comment

... View All >

People Bullish on PDLI

carpet

Analyst

N/A

2 mos ago

atul

Analyst

N/A

2 mos ago

roby1050

Analyst

N/A

4 mos ago

harley3000

Analyst

37%

about 1 year ago

Daniel Jones

Tracked Blogger

30%

about 1 year ago

People Bearish on PDLI

arianac27

Analyst

N/A

about 1 year ago

... View All >

ROCK-STAR INVESTORS

Rank	Name	Sharpe Ratio	Avg Return	Followers
1	noshoes	21.10	+34.37%	379
2	Gerald Greene	18.14	+70.70%	210
3	stockmarketfunding.com	17.66	+25.67%	55
4	akiralegrand	13.47	+14.32%	61
5	anup2104	12.13	+78.05%	39

... more »

POPULAR STOCKS

Symbol	Company Name	Sentiment
YHOO	Yahoo! Inc
PFE	Pfizer Inc
RIO	Companhia Vale Do Rio Doce
DRYS	DryShips Inc.
WMT	WalMart Stores Inc
F	Ford Motor Company

... more »

TODAY'S HEADLINES

LDK Solar's Growth Potential Offset by Gross Margin Pressure
by Paul Cheung (Zacks.com) about LDK

Cisco Systems Still a Wait and See
by Thomas Catino (Ant & Sons) about CSCO

The Merrill Lynch Diet: Starving Shareholders
by Zack Miller (BloggingStocks) about MER

Until Housing Improves, Don't Expect Stocks to Rebound
by J.D. Steinhilber (Agile Investing) about SPY

Google Blows Q2: Multiple Compression to Continue
by Henry Blodget about GOOG

... more »

TODAY'S TOP PICKS

PARD		PARD - Azimuth Opportunity Bets on Poniard's Survival. Should you ? by Ivan Mutaftchiev
PBIO		Under the Radar Healthcare Stocks: Protox, Pressure BioSciences, Un... by Mike Havrilla
ISIS		ISIS - Last Tuesday's Drop Presents a Nice Buy Opportunity by Ivan Mutaftchiev
ABIO		BioMed News Bytes: Transcept, ProUroCare, SciClone, ABIO by Mike Havrilla
NVO		Diabetes Care: Global Investing Opportunities by Mike Havrilla

... more »

StreetInsider.com on PDLI

Form 8-K PDL BIOPHARMA, INC. For: Nov 23

PDL BioPharma Announces Ex-Dividend Date of November 27 for Special Dividend

Form 8-K PDL BIOPHARMA, INC. For: Nov 13

PDL BioPharma (PDLI) Approves Special Dividend

PDL BioPharma Announces Special Dividend Payment

Discussion Wall

+ Add

Be the first to start a discussion and earn 2 points.

... more »

More Resources

About PDL BioPharma Inc - Answers.com

Historical Prices - Yahoo

Message Boards - BoardCentral.com

More Info: Yahoo | Google | Reuters

IN THE PRESS

None of the information contained on SocialPicks.com constitutes a recommendation by SocialPicks or its users that any particular security, portfolio of securities, transaction, or investment strategy is suitable for any specific person. SocialPicks is not responsible for the posts, discussions, and recommendations of the users on the Site. SocialPicks does not provide investment advice. You must make your own independent decisions regarding any security, portfolio of securities, transaction, or investment strategy mentioned on the website. SocialPicks' users' past results are not necessarily indicative of future performance. Neither SocialPicks nor any of its users guarantees any specific outcome or profit, and you should be aware of the real risk of loss in following any strategy or investments discussed on the website. You understand and agree that you use the Site and Services at your own discretion and risk and that you will be solely responsible for any damages that arise from such use. Before acting on any information contained on the website, you should consider whether it is suitable for your particular circumstances and strongly consider seeking advice from your own financial or investment adviser.